INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2011
|
Total net assets |
£97.7m |
|
NAV per share |
175.9p |
|
Share price |
151.0p |
|
Total value of unquoted investments |
£18.3m |
|
Total number of portfolio companies |
69 |
|
Cash |
2% NAV |
|
Cash committed and reserved to unquoted investments |
(9)% NAV |
|
Portfolio companies with < 1 year of cash |
13% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
5.6 |
|
Gilead Sciences |
5.4 |
|
Teva |
4.7 |
|
Micromet |
4.2 |
|
Insulet |
4.1 |
|
Shire |
3.5 |
|
Celgene |
3.3 |
|
EUSA |
3.0 |
|
Aptiv |
2.9 |
|
Pharmaxis |
2.9 |
|
|
----------- |
|
Total |
39.6 |
|
Geographical Allocation |
% |
|
United States |
74 |
|
Europe |
16 |
|
Israel |
5 |
|
Australia |
3 |
|
Cash |
2 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
79 |
|
Unquoted |
19 |
|
Cash |
2 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
13 DECEMBER 2011